-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q3 2024.
- Vir Biotechnology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$231M, a 23.9% decline year-over-year.
- Vir Biotechnology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$609M, a 12.5% increase year-over-year.
- Vir Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$684M, a 182% decline from 2022.
- Vir Biotechnology, Inc. annual Operating Income (Loss) for 2022 was $833M, a 98% increase from 2021.
- Vir Biotechnology, Inc. annual Operating Income (Loss) for 2021 was $421M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)